CB
Colin Bristow UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
37%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
57.1%
Neutral
42.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $10 |
14%
upside
| 2 | – |
–
| 12 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $546 |
18%
upside
| 3 | +0.02% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $112 |
8%
downside
| 1 | – |
–
| 8 Aug ‘25 5 months ago |
|
|
|
Buy
Maintained
| $80 |
3%
upside
| 1 | +75% |
0
%
| 29 Jul ‘25 5 months ago |
|
|
|
Buy
Maintained
| $5 |
34%
upside
| 1 | +30% |
0
%
| 17 Jun ‘25 6 months ago |
|
|
|
Buy
Maintained
| $1 |
26%
downside
| 2 | +72% |
0
%
| 21 May ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $17 |
35%
downside
| 1 | – |
–
| 22 Apr ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $319 |
2%
downside
| 1 | – |
–
| 14 Apr ‘25 9 months ago |
|
|
|
Buy
Maintained
| $4 |
121%
upside
| 1 | +47% |
0
%
| 28 Mar ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $28 |
10%
upside
| 1 | – |
–
| 5 Feb ‘25 11 months ago |
|